## Background: Tissue polypeptide specific antigen (tps) recently was introduced as an indicator of cell proliferation in various tumors. the authors investigated the value of serum tps as a complement to alpha-fetoprotein (afp) in the detection of hepatocellular carcinoma (hcc) in chinese patients
Tissue polypeptide-specific antigen in pediatric patients: Assessment of normal values
β Scribed by Rebhandl, Winfried; Felberbauer, Franz X.; Paya, Kurosh; Rami, Birgit; Bancher-Todesca, Dagmar; Bieglmayer, Christian; Horcher, Ernst
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 143 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Measurement of serum concentrations of tissue polypeptide-specific Antigen (TPS) has been demonstrated to be useful in diagnosis and monitoring of adult epithelial tumors. So far, no data have been available on normal or pathologic TPS values in children. Therefore, the present study was designed to evaluate the normal values of TPS in childhood. Using a commercial enzyme linked immunosorbent assay (ELISA) kit, serum TPS was determined in 361 healthy children. Median (M) TPS was found to be 107 U/l at birth (n = 124). By the end of the first week, the value rose to M = 150 U/l (n = 68) and then continuously decreased with age (1 week-1 year, n = 45, M = 88 U/l; 1-7 years, n = 75, M = 51 U/l) until reaching the adult level (8-18 years, n = 49, M = 34 U/l). Additionaly, the serum TPS values of 45 mothers right after delivery (M = 161 U/l) were assessed, and there was no correlation to the marker levels determined in the cord blood of their children. The age-dependent distribution of serum TPS in healthy children must be taken into account in the clinical application of this tumor marker. Med. Pediatr. Oncol. 29:218-221, 1997.
π SIMILAR VOLUMES
This retrospective study includes 425 serological examinations of 40 patients with epithelial ovarian cancer and 356 serological examinations of 33 patients with squamous cell cervical cancer. The serum levels of the tumor markers tissue polypeptide specific antigen (TPS), carbohydrate antigen 125 (
Our aim was to evaluate the clinical usefulness of serum concentrations of squamous-cell carcinoma antigen (SCC-Ag) and tissue polypeptide antigen (TPA) in the follow-up of patients with vulvar cancer. We measured SCC-Ag and TPA in 480 serum samples of 82 patients with squamous-cell vulvar cancer. R
BACKGROUND. The present study evaluated monthly measurements of free and total prostate-specific antigen (PSA), and the tumor proliferation markers tissue polypeptide-specific antigen (TPS) and cytokeratin fragment 21-1 (CYFRA 21-1) in patients with advanced prostate cancer receiving intermittent an